EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Prevalence of polypharmacy and potentially inappropriate prescribing in older adults with a prognosis of 6 months or less: a systematic review and meta-analysis

Xin Er Yaw iD, Yen Jun Wong, Wing Loong Cheong, J Simon Bell iD, Ednin Hamzah, Shaun Wen Huey Lee iD

Age and Ageing · 31.10.2026 · 55 (11)

DOI: 10.1093/ageing/afag326 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Age and Ageing, online erschienen am 13.11.2026. Verfasst von Xin Er Yaw und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, 47500 Subang Jaya, Selangor, Malaysia. Hauptthemen laut MEDLINE: Inappropriate Prescribing, Polypharmacy, Potentially Inappropriate Medication List. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polypharmacy and potentially inappropriate medications (PIMs) are common in older adults, but the prevalence in those with a prognosis of 6 months or less is poorly characterised. We estimated the prevalence of polypharmacy, PIMs and potential prescribing omissions (PPOs) in older adults approaching end of life.

Methods

We systematically searched six databases from inception to 30 April 2026, for studies reporting polypharmacy (≥5 medications) or PIMs in adults aged ≥65 years with life-limiting illnesses (≤6-month prognosis). Two reviewers independently screened records, extracted data and assessed bias using Joanna Briggs Institute or Newcastle-Ottawa tools. Pooled prevalence used random-effects models. Heterogeneity was explored by setting, region and assessment tool. The review was registered with PROSPERO (CRD42023454636).

Findings

Eighteen studies (499 853 participants, 52.3% female) were included in this review. Pooled prevalence of polypharmacy was 76% (95% CI 65%–87%) with excessive polypharmacy (≥10 medications) at 34% (9%–58%). PIM prevalence was high at 54% (40%–68%), and remained above 50% until the final week of life, with preventive medications (statins, antithrombotics, proton pump inhibitors) often continued until death. Substantial heterogeneity was present in all pooled analyses (I2 > 99%), highlighting considerable variability across studies. Only two studies assessed PPOs 30% lacked prophylactic laxatives with opioids while 76.6% lacked strong opioids for moderate–severe cancer pain.

Interpretation

Polypharmacy and PIMs use are highly prevalent among people with limited life prognosis, suggesting that evidence-based deprescribing protocols are needed for this vulnerable population. Nevertheless, this needs to be taken in light of the substantial heterogeneity of PIM definitions, underscoring the need for standardised PIM assessment in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inappropriate PrescribingPolypharmacyPotentially Inappropriate Medication ListHumansAgedPrognosisPrevalenceAged, 80 and overTime Factors

Stichwörter der Autor:innen

deprescribingend of lifeolder peoplepalliative carepolypharmacypotentially inappropriate medications (PIM)systematic review

Autor:innen und Institutionen

  • School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, 47500 Subang Jaya, Selangor, Malaysia.
  • Monash University Faculty of Pharmacy and Pharmaceutical Sciences, Centre for Medicine Use and Safety, Parkville, VIC 3052, Australia.
  • Hospis Malaysia, Cheras, Kuala Lumpur, Malaysia.

ORCID-Profile: Xin Er Yaw, J Simon Bell, Shaun Wen Huey Lee

Zitieren

APA

Yaw, X. E., Wong, Y. J., Cheong, W. L., Bell, J. S., Hamzah, E., & Lee, S. W. H. (2026). Prevalence of polypharmacy and potentially inappropriate prescribing in older adults with a prognosis of 6 months or less: a systematic review and meta-analysis. Age and Ageing, 55(11). https://doi.org/10.1093/ageing/afag326

Vancouver

Yaw XE, Wong YJ, Cheong WL, Bell JS, Hamzah E, Lee SWH. Prevalence of polypharmacy and potentially inappropriate prescribing in older adults with a prognosis of 6 months or less: a systematic review and meta-analysis. Age and Ageing. 2026;55(11). doi:10.1093/ageing/afag326

BibTeX
@article{Yaw2026,
  author = {Yaw, Xin Er and Wong, Yen Jun and Cheong, Wing Loong and Bell, J Simon and Hamzah, Ednin and Lee, Shaun Wen Huey},
  title = {Prevalence of polypharmacy and potentially inappropriate prescribing in older adults with a prognosis of 6 months or less: a systematic review and meta-analysis},
  journal = {Age and Ageing},
  year = {2026},
  volume = {55},
  number = {11},
  doi = {10.1093/ageing/afag326}
}
Kostenlos starten →